{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:11:26Z","timestamp":1791609086760,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,7,15]],"date-time":"2015-07-15T00:00:00Z","timestamp":1436918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00228-015-1895-y","type":"journal-article","created":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T21:20:55Z","timestamp":1436822455000},"page":"1129-1138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990\u20132012"],"prefix":"10.1007","volume":"71","author":[{"given":"Thomas","family":"Stammschulte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf-Dieter","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"M\u00fchlbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Bronder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Gundert-Remy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,15]]},"reference":[{"key":"1895_CR1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.21307\/immunohematology-2019-103","volume":"30","author":"BR Curtis","year":"2014","unstructured":"Curtis BR (2014) Drug-induced immune neutropenia\/agranulocytosis. Immunohematology 30:95\u2013101","journal-title":"Immunohematology"},{"key":"1895_CR2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/B:EJEP.0000032371.97823.85","volume":"19","author":"H Theophile","year":"2004","unstructured":"Theophile H, Begaud B, Martin K et al (2004) Incidence of agranulocytosis in Southwest France. Eur J Epidemiol 19:563\u2013565","journal-title":"Eur J Epidemiol"},{"key":"1895_CR3","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1365-2125.1993.tb04157.x","volume":"35","author":"MM Klauw van der","year":"1993","unstructured":"van der Klauw MM, Stricker BH, Herings RM et al (1993) A population based case-cohort study of drug-induced anaphylaxis. Br J Clin Pharmacol 35:400\u2013408","journal-title":"Br J Clin Pharmacol"},{"key":"1895_CR4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00228-013-1618-1","volume":"70","author":"M Huber","year":"2014","unstructured":"Huber M, Andersohn F, Bronder E et al (2014) Drug-induced agranulocytosis in the Berlin case-control surveillance study. Eur J Clin Pharmacol 70:339\u2013345","journal-title":"Eur J Clin Pharmacol"},{"key":"1895_CR5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ajh.21433","volume":"84","author":"D Tesfa","year":"2009","unstructured":"Tesfa D, Keisu M, Palmblad J (2009) Idiosyncratic drug-induced agranulocytosis: possible mechanisms and management. Am J Hematol 84:428\u2013434","journal-title":"Am J Hematol"},{"key":"1895_CR6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0609.1996.tb01651.x","volume":"60","author":"JP Uetrecht","year":"1996","unstructured":"Uetrecht JP (1996) Reactive metabolites and agranulocytosis. Eur J Haematol Suppl 60:83\u201388","journal-title":"Eur J Haematol Suppl"},{"key":"1895_CR7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ajh.2830310314","volume":"31","author":"JB Hargis","year":"1989","unstructured":"Hargis JB, La Russa VF, Redmond J et al (1989) Agranulocytosis associated with \u201cMexican aspirin\u201d (dipyrone): evidence for an autoimmune mechanism affecting multipotential hematopoietic progenitors. Am J Hematol 31:213\u2013215","journal-title":"Am J Hematol"},{"key":"1895_CR8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2141.1989.tb07672.x","volume":"72","author":"A Salama","year":"1989","unstructured":"Salama A, Schutz B, Kiefel V et al (1989) Immune-mediated agranulocytosis related to drugs and their metabolites: mode of sensitization and heterogeneity of antibodies. Br J Haematol 72:127\u2013132","journal-title":"Br J Haematol"},{"key":"1895_CR9","unstructured":"FDA: List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness (Federal Register: October 8, 1998 (Volume 63, Number 195)): http:\/\/www.fda.gov\/ohrms\/dockets\/98fr\/100898b.txt . Accessed 6 Jul 2013."},{"key":"1895_CR10","doi-asserted-by":"crossref","first-page":"f4366","DOI":"10.1136\/bmj.f4366","volume":"347","author":"S Bhaumik","year":"2013","unstructured":"Bhaumik S (2013) India's health ministry bans pioglitazone, metamizole, and flupentixol-melitracen. BMJ 347:f4366","journal-title":"BMJ"},{"key":"1895_CR11","unstructured":"Arzneimittelkommission der deutschen \u00c4rzteschaft: Bundesgesundheitsamt schr\u00e4nkt Anwendungsgebiet von Metamizol-haltigen Monopr\u00e4paraten ein. Dtsch Arztebl 1986;83:3267."},{"key":"1895_CR12","doi-asserted-by":"crossref","unstructured":"Schwabe U, Paffrath D (Hrsg.): Arzneiverordnungs-Report (German Drug Report) 2013. Berlin, Heidelberg: Springer Medizin Verlag; 2013","DOI":"10.1007\/978-3-642-37124-0"},{"key":"1895_CR13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00228-004-0836-y","volume":"60","author":"L Ibanez","year":"2005","unstructured":"Ibanez L, Vidal X, Ballarin E, Laporte JR (2005) Agranulocytosis associated with dipyrone (metamizol). Eur J Clin Pharmacol 60:821\u2013829","journal-title":"Eur J Clin Pharmacol"},{"key":"1895_CR14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00228-014-1777-8","volume":"71","author":"M Huber","year":"2014","unstructured":"Huber M, Andersohn F, Sarganas G et al (2014) Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study. Eur J Clin Pharmacol 71:219\u2013227","journal-title":"Eur J Clin Pharmacol"},{"key":"1895_CR15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00228-014-1781-z","volume":"71","author":"LS Blaser","year":"2015","unstructured":"Blaser LS, Tramonti A, Egger P et al (2015) Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports. Eur J Clin Pharmacol 71:209\u2013217","journal-title":"Eur J Clin Pharmacol"},{"key":"1895_CR16","unstructured":"(Muster-)Berufsordnung f\u00fcr die in Deutschland t\u00e4tigen \u00c4rztinnen und \u00c4rzte [(Model) Professional Code for Physicians in Germany]: http:\/\/www.bundesaerztekammer.de\/downloads\/MBO_08_20112.pdf . Kiel, 114th German Medical Assembly 2011. Accessed 6 June 2014."},{"key":"1895_CR17","unstructured":"Development and rational use of standardised MedDRA Queries (SMQs). Geneva: Council for International Organizations of Medical Sciences (CIOMS); 2004."},{"key":"1895_CR18","unstructured":"World Health Organization: The use of the WHO-UMC system for standardised case causality assessment: http:\/\/who-umc.org\/Graphics\/24734.pdf . Accessed 10 June 2015."},{"key":"1895_CR19","first-page":"813","volume":"36","author":"T Stammschulte","year":"2013","unstructured":"Stammschulte T, Pachl H, Gundert-Remy U (2013) Do older patients take more drugs and are they at higher risk of adverse drug reactions? What do our spontaneous reports say? Drug Saf 36:813","journal-title":"Drug Saf"},{"key":"1895_CR20","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00228-008-0513-7","volume":"64","author":"N Hamerschlak","year":"2008","unstructured":"Hamerschlak N, Maluf E, Biasi CA et al (2008) Incidence and risk factors for agranulocytosis in Latin American countries\u2014the Latin Study: a multicenter study. Eur J Clin Pharmacol 64:921\u2013929","journal-title":"Eur J Clin Pharmacol"},{"key":"1895_CR21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archinte.165.8.869","volume":"165","author":"L Ibanez","year":"2005","unstructured":"Ibanez L, Vidal X, Ballarin E, Laporte JR (2005) Population-based drug-induced agranulocytosis. Arch Intern Med 165:869\u2013874","journal-title":"Arch Intern Med"},{"key":"1895_CR22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4269\/ajtmh.1999.60.573","volume":"60","author":"S Shapiro","year":"1999","unstructured":"Shapiro S, Issaragrisil S, Kaufman DW et al (1999) Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group. Am J Trop Med Hyg 60:573\u2013577","journal-title":"Am J Trop Med Hyg"},{"key":"1895_CR23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00228-002-0465-2","volume":"58","author":"K Hedenmalm","year":"2002","unstructured":"Hedenmalm K, Spigset O (2002) Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol 58:265\u2013274","journal-title":"Eur J Clin Pharmacol"},{"key":"1895_CR24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0953-6205(02)00085-7","volume":"13","author":"E Andres","year":"2002","unstructured":"Andres E, Maloisel F, Kurtz JE et al (2002) Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature. Eur J Intern Med 13:324\u2013328","journal-title":"Eur J Intern Med"},{"key":"1895_CR25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","volume":"146","author":"F Andersohn","year":"2007","unstructured":"Andersohn F, Konzen C, Garbe E (2007) Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 146:657\u2013665","journal-title":"Ann Intern Med"},{"key":"1895_CR26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0090-1229(82)90233-1","volume":"24","author":"N Gualde","year":"1982","unstructured":"Gualde N, Malinvaud G (1982) In vitro generation of cytotoxic lymphocytes during noramidopyrine-induced agranulocytosis. Clin Immunol Immunopathol 24:220\u2013226","journal-title":"Clin Immunol Immunopathol"},{"key":"1895_CR27","unstructured":"Sanofi-Aventis Deutschland GmbH: Fachinformation \u201cNovalgin\u00ae\u201d. Stand: Januar 2011."},{"key":"1895_CR28","unstructured":"Arzneimittelkommission der deutschen \u00c4rzteschaft: \u201cAus der UAW-Datenbank\u201d: Agranulozytose nach Metamizol - sehr selten, aber h\u00e4ufiger als gedacht. Dtsch Arztebl 2011;108:A 1758-1759."},{"key":"1895_CR29","unstructured":"BfArM: Metamizol (Novalgin, Berlosin, Novaminsulfon, etc.): BfArM weist auf richtige Indikationsstellung und Beachtung von Vorsichtsma\u00dfnahmen und Warnhinweisen hin (28.05.2009): http:\/\/www.bfarm.de\/DE\/Pharmakovigilanz\/risikoinfo\/Archiv\/2009\/RI-metamizol.html . Accessed 6 Jul 2013."}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1895-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-015-1895-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1895-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T19:31:26Z","timestamp":1717961486000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-015-1895-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,15]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["1895"],"URL":"https:\/\/doi.org\/10.1007\/s00228-015-1895-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,15]]}}}